Diabetes - type 2. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified
Conditions
Interventions
Intervention 1: Intervention group: This group will receive 300 mg capsules of alphalipoic acid (Raha Pharmaceutical Company) twice a day. In order to receive the capsule, the necessary educational ex
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 74 Years
Inclusion criteria
Inclusion criteria: Age 18 to 74 years, Type 2 diabetes, duration of diabetes more than one year, presence of peripheral neuropathy (pain) in the examination, symptoms of neuropathy (pain) for at least one month, score more than three in the pain diagnostic questionnaire.
Exclusion criteria
Exclusion criteria: neurological disease such as MS Severe liver or kidney disease Antioxidant consumption in the last three months The presence of cancer and malignancy and chemotherapy Pregnancy and breastfeeding Peripheral arterial disease diabetic foot ulcer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropathy. Timepoint: At the beginning of the study and then once a month until the completion of the probationary period. Method of measurement: Physical examination.;Pain. Timepoint: At the beginning of the study and then once a month until the completion of the probationary period. Method of measurement: visual analog scale for pain. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahdi Shafiee Sabet
Tehran University of Medical Sciences
Outcome results
None listed